---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-045275"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-10-01T13:00:50+00:00"
generated_at: "2026-10-12T14:18:17.045141+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Daré Bioscience to use Oct 1, 2026 investor presentation in meetings; exhibit content not filed

## Summary
- A corporate presentation dated October 1, 2026 is to be used in meetings with securities market participants and others, starting October 1, 2026.
- The presentation is to be posted in the 'Investors' section of ir.darebioscience.com under 'Presentations, Events & Webcasts' > 'Presentations'.
- The filing references Exhibit 99.1 but the presentation text was not included, so no financial, clinical, or pipeline figures can be reported.
- Item 7.01 Regulation FD disclosure; no revenue, guidance, trial data, partnership, or financing terms appear anywhere in the text provided.

## SEC filing metadata
- accession: 0001493152-26-045275
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-10-01T13:00:50+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315226045275/0001493152-26-045275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226045275/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-045275
- JSON: https://secwatch.observer/filing/0001493152-26-045275.json
- Plain text: https://secwatch.observer/filing/0001493152-26-045275.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.